Enovis - 15 Year Stock Price History | ENOV
Historical daily share price chart and data for Enovis since 2011 adjusted for splits and dividends. The latest closing stock price for Enovis as of June 17, 2026 is 20.85.
- The all-time high Enovis stock closing price was 128.95 on July 01, 2014.
- The Enovis 52-week high stock price is 36.82, which is 76.6% above the current share price.
- The Enovis 52-week low stock price is 20.55, which is 1.4% below the current share price.
- The average Enovis stock price for the last 52 weeks is 27.13.
| Enovis Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 23.7447 | 26.5100 | 29.6800 | 20.8500 | 20.8500 | -21.73% |
| 2025 | 33.7118 | 44.3000 | 47.9900 | 25.7400 | 26.6400 | -39.29% |
| 2024 | 49.9288 | 55.4400 | 63.8000 | 38.7200 | 43.8800 | -21.67% |
| 2023 | 55.7392 | 54.4000 | 65.9200 | 43.6700 | 56.0200 | 4.67% |
| 2022 | 60.2982 | 79.9312 | 80.8434 | 44.8300 | 53.5200 | -32.36% |
| 2021 | 78.5433 | 63.7866 | 91.1704 | 63.7866 | 79.1222 | 20.21% |
| 2020 | 53.1462 | 63.7005 | 66.9535 | 25.1979 | 65.8176 | 5.11% |
| 2019 | 48.9997 | 35.9897 | 62.7539 | 34.7504 | 62.6162 | 74.07% |
| 2018 | 54.7731 | 68.5370 | 71.8761 | 33.0465 | 35.9725 | -47.25% |
| 2017 | 67.9561 | 63.5112 | 74.2857 | 60.0344 | 68.1928 | 10.27% |
| 2016 | 50.2789 | 40.8606 | 68.4165 | 33.2014 | 61.8417 | 53.88% |
| 2015 | 69.9635 | 89.7418 | 92.0310 | 37.8657 | 40.1893 | -54.72% |
| 2014 | 110.5501 | 108.7610 | 128.9500 | 81.2392 | 88.7608 | -19.03% |
| 2013 | 87.6446 | 72.2719 | 109.6210 | 69.6041 | 109.6210 | 57.84% |
| 2012 | 57.0290 | 48.6231 | 69.4492 | 42.6850 | 69.4492 | 41.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.405B | $2.248B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |